Related references
Note: Only part of the references are listed.Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study
Juergen Braun et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Radiographic Severity of Ankylosing Spondylitis Is Associated With Polymorphism of the Large Multifunctional Peptidase 2 Gene in the Spondyloarthritis Research Consortium of Canada Cohort
Nigil Haroon et al.
ARTHRITIS AND RHEUMATISM (2012)
The balance of tissue repair and remodeling in chronic arthritis
Rik Lories
NATURE REVIEWS RHEUMATOLOGY (2011)
Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine
R. Landewe et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years
Desiree van der Heijde et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Efficacy and Safety of Golimumab in Patients With Ankylosing Spondylitis Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
Robert D. Inman et al.
ARTHRITIS AND RHEUMATISM (2008)
Radiographic Findings Following Two Years of Infliximab Therapy in Patients With Ankylosing Spondylitis
Desiree van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2008)
Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept
D. van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2008)
Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab
S. Visvanathan et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-α antibody infliximab
X. Baraliakos et al.
RHEUMATOLOGY (2007)
Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes
X. Baraliakos et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab
J Sieper et al.
RHEUMATOLOGY (2005)
Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system
MCW Creemers et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Share Paper
